Sharma, S and Rajesh, R and Saini, NK and Pareek, S and Mangal, R (2011) Adiponectin in Nash and Role of Pioglitazone. Inventi Rapid: Pharmacy Practice, 2011 (2). ISSN 0976-3848

PDF 102_RR.pdf - Published Version Restricted to Registered users only Download (309kB) | Request a copy

Abstract

Non-alcoholic steatohepatitis (NASH) is associated with many clinical characteristics including Type 2 diabetes mellitus and obesity which collectively termed as metabolic syndrome or the insulin resistance syndrome. Adiponectin is an adipokines which help to prevent the development of NASH and cirrhosis. Pioglitazone therapy is associated with improvements in steatosis, parenchymal inflammation, cell injury, and fibrosis. Adiponectin level in plasma are increased by pioglitazone treatment that improves steatosis and necroinflammation

Item Type:	Article
Uncontrolled Keywords:	NASH, NAFLD, Adiponectin, Pioglitazone
Subjects:	Pharmacy > MCOPS Manipal > Pharmacy Practice
Depositing User:	KMC Manipal
Date Deposited:	11 Jul 2011 06:14
Last Modified:	11 Jul 2011 06:15
URI:	http://eprints.manipal.edu/id/eprint/515

Actions (login required)

View Item